8-Bromo-3-Methylxanthine CAS 93703-24-3 Tsabtace Tsabtace Tsabtace Linagliptin ≥99.0% Hoton Factory

8-Bromo-3-Methylxanthine CAS 93703-24-3 Tsabtace Tsabtace Tsabtace Linagliptin ≥99.0% Factory

Takaitaccen Bayani:

Sunan Sinadari: 8-Bromo-3-Methylxanthine

Saukewa: 93703-24-3

Tsafta: ≥99.0%

Bayyanar: Fari zuwa Hasken Foda na Yellow

Matsakaici don Linagliptin (CAS: 668270-12-0) don maganin nau'in ciwon sukari na II.

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Samar da Linagliptin na masana'anta da Matsakaici masu alaƙa:
Linagliptin CAS 668270-12-0
Linagliptin Iyayen Nucleus Matsakaici CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7- (2-butyn-1-yl) -3-methylxanthine CAS 666816-98-4
2- (Chloromethyl) -4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino) Piperidine CAS 309956-78-3
(R)-(-)-3-Aminopperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Abubuwan Sinadarai:

Sunan Sinadari	8-Bromo-3-Methylxanthine
Makamantu	8-Bromo-3-Methyl-3,7-dihydro-1H-purine-2,6-dione
Lambar CAS	93703-24-3
Lambar CAT	Saukewa: RF-PI501
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C6H5BrN4O2
Nauyin Kwayoyin Halitta	245.03
Matsayin narkewa	300 ℃ (lit.)
Yawan yawa	1.974g/cm 3
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Fari zuwa Hasken Fada mai Rawaya
Tsafta	≥99.0%
Asara akan bushewa	≤0.50%
Ragowa akan Ignition	≤0.50%
Rashin Tsabtace Guda Daya	≤0.50%
Jimlar ƙazanta	≤1.0%
Karfe masu nauyi	≤20ppm
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	Matsakaici na Linagliptin (CAS: 668270-12-0)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

FAQ:

Aikace-aikace:

8-Bromo-3-Methylxanthine (CAS: 93703-24-3) wani canji ne na Xanthine.Ana iya amfani da shi don haɗin linagliptin (CAS: 668270-12-0), wanda shine sabon labari mai ƙarfi da zaɓin dipeptidyl peptidase-4 (DPP-4) mai hanawa tare da yuwuwar amfani a cikin kula da nau'in ciwon sukari na 2.FDA ta Amurka ta amince da ita a watan Mayu 2011 don kula da nau'in ciwon sukari na 2 tare da abinci da motsa jiki. Mafarin shine Boehringer Ingelheim (Amurka).